rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew H. Galligan

Director

Company insider

Files Form 4 as: Director, Ooma; Director, Arcellx; Chief Financial Officer, Nevro; Director, diaDexus.

In numbers

Trades disclosed
148
Buys
0
Sells
20
Bought
$0
Sold
$16.6M
Companies
4
Companies where not an officer
3
First trade
4 Nov 2010
Last trade
4 Jun 2026
Last filed
8 Jun 2026

Companies traded

Where they are an officer
NevroOfficer · last 4 Jun 20200 buys · 16 sells
Everywhere else they filed: board seats, 10% stakes, other companies
OOMA OomaDirector · Payments & Processors · last 4 Jun 20260 buys · 4 sells
ArcellxDirector · Biotechnology · last 28 Apr 20260 buys · 0 sells
diaDexusDirector · last 29 May 20140 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Jun 2026filed 8 Jun 2026OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—9,743 at $0.00filing
4 Jun 2026filed 8 Jun 2026OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—9,743 at $0.00filing
28 Apr 2026filed 28 Apr 2026ArcellxBiotechnologySEC FORM 4 Code U—5,000filing
28 Apr 2026filed 28 Apr 2026Arcellxoption or derivative · BiotechnologySEC FORM 4 Code D—16,829filing
28 Apr 2026filed 28 Apr 2026Arcellxoption or derivative · BiotechnologySEC FORM 4 Code D—1,784filing
28 Apr 2026filed 28 Apr 2026Arcellxoption or derivativeSEC FORM 4 Code D—16,829filing
28 Apr 2026filed 28 Apr 2026Arcellxoption or derivativeSEC FORM 4 Code D—1,784filing
28 Apr 2026filed 28 Apr 2026ArcellxSEC FORM 4 Code U—5,000filing
23 Jun 2025filed 24 Jun 2025OOMA OomaPayments & ProcessorsSEC FORM 4 Sold$154K12,407 at $12.43filing
5 Jun 2025filed 9 Jun 2025OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—11,556 at $0.00filing
29 May 2025filed 30 May 2025Arcellxoption or derivativeSEC FORM 4 Code A—1,784 at $0.00filing
18 Mar 2025filed 20 Mar 2025Arcellxoption or derivativeSEC FORM 4 Code A—16,829 at $0.00filing
17 Dec 2024filed 19 Dec 2024OOMA Oomaoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—35,000 at $0.00filing
17 Dec 2024filed 19 Dec 2024OOMA OomaPayments & ProcessorsSEC FORM 4 Code M$211K35,000 at $6.04filing
17 Dec 2024filed 19 Dec 2024OOMA OomaPayments & ProcessorsSEC FORM 4 Sold$216K14,824 at $14.56filing
6 Jun 2024filed 7 Jun 2024OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—19,762 at $0.00filing
1 Jun 2023filed 5 Jun 2023OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—11,783 at $0.00filing
1 Jun 2022filed 3 Jun 2022OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—11,355 at $0.00filing
2 Jun 2021filed 4 Jun 2021OOMA OomaPayments & ProcessorsSEC FORM 4 Code A—7,498 at $0.00filing
4 Jun 2020filed 8 Jun 2020NevroSEC FORM 4 Code F$281K2,311 at $121.53filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Financials4
Not placed16

Buys in green, sells in red, by the company’s sector.

Related people

Namrata SabharwalVP & Chief Accounting Officer · Also traded OOMA in the last 90 days
Susan ButenhoffDirector · Also traded OOMA in the last 90 days
Jenny C. YehSVP & Chief Legal Officer · Also traded OOMA in the last 90 days
Eric B. StangPresident & CEO · Also traded OOMA in the last 90 days
Shigeyuki HamamatsuSVP & Chief Financial Officer · Also traded OOMA in the last 90 days